SEC Form 4 · accession 0000899243-16-018233
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John B Green
Officer — Chief Financial Officer
Period of report
Apr 14, 2016
Accepted (ET)
Apr 18, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $5.45 | Apr 14, 2016 | A | 265,000 | A | — | Apr 14, 2026 | Common Stock | 265,000 | 265,000 | D |
Explanation of responses
- F1The option vests 25% after the first year anniversary of the vesting start date of April 14, 2016 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date.